Kalorama Information is a dependable resource for information on opportunity in the pharmaceutical market. The pharma industry has seen important developments in the last few years, bringing both challenges and new opportunities. The industry outlook for many manufacturers has changed due to outsourcing in drug discovery, growing generic competition and greater interest in biotechnology, among other developments. Our reports provide the sales data, revenue forecasts, and competitive analysis that one needs to understand the market.
Vaccines
Drug Delivery
Over-the-Counter
Drug Discovery
Cancer Treatment
Manufacturing & Packaging
Prescription Drugs

    Vaccines 2014: World Market Analysis with Forecasts to 2020, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)

    Published: April 21, 2014 | Price: $995.00 – $1,990.00

    Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments The global market for human vaccines experienced strong growth through 2013 with the introduction of new vaccines. These new products and other trends are well-covered in Vaccines: The World Market. The Kalorama information report examines the global market for vaccines, covering specifically commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable. Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission....
    The World Anesthesia Drug Market (General, Local, Adjunctive)

    Published: March 22, 2012 | Price: $3,500.00 – $7,000.00

    This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia  Local Anesthesia  Adjunctive Therapies in Anesthesia  The report covers both currently marketed and late stage development anesthesia drugs.  For each of these segments the report contains: Products on the Market Products in Development Market Size and Forecast Market Share of Key Players Issues and Trends Revenues for each segment were generated using dollar and unit sales for each product.  Forecasted...
    Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market)

    Published: August 29, 2014 | Price: $3,995.00 – $7,990.00

    Biopharmaceutical and Vaccine Production Markets Biopharmaceutical and Vaccine Production Markets analyzes the entire manufacturing market for biologic drugs, including both outsourcing and costs by major maufacturers spending internally on biopharmaceutical and vaccine production. As part of its coverage, the following information is provided Market Size and Projections Vaccine Manufacturing Estimates Biologic Drug Methods Trend Analysis Types of Production Outsourcing Market Regulation of the Market Competitor Profiles This study contains production segmentations for the mammalian cell, microbial cell, monoclonal antibody, other...
    The World Anesthesia Drug Market

    Published: April 1, 2010 | Price: $3,995.00 – $7,990.00

    This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies in Anesthesia The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors. The report includes statistical...
    The Worldwide Market for Prescription Cardiovascular Drugs

    Published: May 1, 2005 | Price: $3,500.00 – $7,000.00

    The worldwide market for prescription cardiovascular drugs encompasses a wide variety of products that treat the many facets of cardiovascular disease. The field of cardiology is currently experiencing a busy and dynamic period. As a result, the range of therapeutic options available to physicians has expanded significantly in the past few years and the development pipeline promises even more weapons soon. The sheer size and diversity of the current market and the potential of new products make this therapeutic category...
    Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023

    Published: December 8, 2023 | Price: $5,000.00 – $10,000.00

    While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years.  Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area.  There are now many approved therapies with proven track records. As the technologies have lowered the barriers to entry for the industry, over 1,500 therapy or tools companies have been...
    HIV – A Strategic Analysis of Therapeutic and Testing Markets

    Published: March 1, 2006 | Price: $3,500.00 – $7,000.00

    The strategic interplay of of HIV/AIDS diagnostics and therapeutics is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS, companies must think on a global basis, and in addition to the basic pathology and complications of HIV/AIDS, there are societal and ethical pressures, geopolitical factors, and evolving marketplace disruptions. For the development of a coherent strategy in this therapeutic area, companies must clearly focus on three...
    Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

    Published: September 19, 2012 | Price: $1,500.00 – $3,000.00

    This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these and other not-yet-vaccine-preventable conditions are...
    Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems (Markets for Needle-Free, Targeted Injectable, Sustained-Release Implantable and Other Systems)

    Published: February 1, 2007 | Price: $2,995.00 – $4,990.00

    Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010. Kalorama’s Drug Delivery Markets. Edition...
    Outsourcing in Drug Discovery, 2nd Edition

    Published: January 1, 2006 | Price: $2,995.00 – $5,990.00

    In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed to make readers aware of the enormous changes that are taking place in the drug discovery outsourcing market, and the forces that are shaping the sector. It presents viewpoints from both customers...
    U.S. Market for OTC Diet Aids, The

    Published: February 1, 2004 | Price: $3,000.00 – $6,000.00

    Diet Aids are among the most rapidly growing categories of over-the-counter (OTC) products. Between 1998 and 2003, growth was driven by two main factors: changes in laws and lawsuits relating to the industry, and changes in consumer attitudes toward weight loss. Because both of these factors are subject to rapid and unpredictable shifts, the diet aids category remains a highly volatile market. The consumer attitude towards OTC diet aids has shown extreme changes during the last couple of years. While...
    Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery

    Published: February 18, 2006 | Price: $2,200.00 – $5,990.00

    Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the traditional injection is still the dominant paradigm. However, the staggering costs and intransigent safety problems associated with sharps, along with consumer demand and the move to alternate-site care, are pushing for alternatives to traditional needles and syringes faster than advanced delivery technologies can...
    RFID in Pharmaceutical Manufacturing: Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies

    Published: March 1, 2008 | Price: $995.00 – $3,990.00

    Pharmaceutical manufacturers are utilizing new RIFD technologies to deal with multiple challenges they face in the manufacturing process. This Kalorama Information report discussions the solutions available, and covers the opportunities available to technology companies to provide services to this sector. Full coverage of the market for RFID technologies in pharmaceutical manufacturing operations is provided, including.   Explanation of RFID Technologies Cost Savings from Implementation Total Market for RFID Technologies in Pharma Manufacturing Market Forecasts Major Companies Involved in RFID and...
    The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery

    Published: November 1, 2003 | Price: $1,875.00 – $3,750.00

    The process of creating a new drug is lengthy and complex. From discovery to development to market, there are numerous pitfalls. In this report, Kalorama focuses on one of the trickiest yet also most promising areas: the interface between discovery and development known as lead optimization. The pressure is on: get better lead compounds faster and at less cost. The amount of money wasted on leads that fail is excessive. And the attrition rate to get a lead is huge....
    Biosimilars: Global Market, Trends and Competitor Analysis

    Published: November 14, 2017 | Price: $3,600.00 – $7,200.00

    Biosimilars: Global Market, Trends and Competitor Analysis Biosimilars: Global Market, Trends, and Competitor Analysis is a detailed analysis both of the market for biosimilars and for the market effects on pharmaceutical markets. The report provides a complete picture of the biosimilars market, including information on the world, United States, EU, Germany, France, UK, Italy Spain, rest of Europe, Russia, Japan, India, China, South Korea, Australia, Brazil, Mexico, Turkey, Iran, Canada and rest of world biosimilars market to 2022. The report...